177 related articles for article (PubMed ID: 37039264)
1. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
2. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
Jin W; Ye L
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
[TBL] [Abstract][Full Text] [Related]
3. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A.
Zhang M; Ren Z; Wang X; Liu C; Zheng Z; Zhao J; Liu H
Anal Cell Pathol (Amst); 2022; 2022():7005328. PubMed ID: 36046597
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
6. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
7. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
[TBL] [Abstract][Full Text] [Related]
8. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-152 specifically targets kinesin family member 14 to suppress the advancement of bladder cancer cells via PI3K/AKT pathway.
Meng F; Zhang Z
Biochem Biophys Res Commun; 2024 Jan; 692():149337. PubMed ID: 38070277
[TBL] [Abstract][Full Text] [Related]
10. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
11. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
12. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
[TBL] [Abstract][Full Text] [Related]
13. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
14. EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
Zhang S; Liu J; Li F; Yang M; Wang J
Gene; 2022 May; 822():146317. PubMed ID: 35182680
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
16. Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway.
Xu Q; Li X; Li Y; Yu J; Yang A
Funct Integr Genomics; 2023 May; 23(2):154. PubMed ID: 37162618
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma.
Qin L; Jia Z; Xie D; Liu Z
J Cell Biochem; 2018 Dec; 119(12):10075-10086. PubMed ID: 30129054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]